HL22
HL22 is a harmaline derivative. HL22 significantly inhibits HCT116, MGC803 and MCF7 cancer cell lines, and inhibits MGC803 cell migration and monoclonal formation. The anti-cancer mechanism of HL22 is related to a variety of metabolic pathways and can be used in the study of cancer[1].
Product Specifications
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Smiles
COC1=CC=C2C(N(CCCCCN3C4=CC(OC)=CC=C4C5=C3C(C)=NCC5)C6=C2C=CN=C6C)=C1
Molecular Formula
C31H34N4O2
Molecular Weight
494.63
References & Citations
[1]Liu Y, et al. Synthesis of harmaline N-9 derivatives and investigation of in vitro anticancer activity. Bioorg Med Chem Lett. 2025 Jan 13;119:130106.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-172097/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15368348 1 Vial
Lentiviral human XKR6 sgRNA gene knockout kit - Lentiviral human XKR6 sgRNA gene knockout kit (plasmid)
Ask
View Details ![Mouse Monoclonal vWF-A2 Antibody (VWF/4458) [Alexa Fluor 750]](https://cdn.genprice.uk/genprice/genprice4.png)
NBP3-27026AF750 0.1 mL
Mouse Monoclonal vWF-A2 Antibody (VWF/4458) [Alexa Fluor 750]
Ask
View Details